Innate Pharma S.A.
IPH.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €66 | €71 | €84 | €104 |
| Short-Term Investments | €14 | €22 | €17 | €16 |
| Receivables | €5 | €46 | €31 | €13 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €0 | €9 | €7 | €5 |
| Total Curr. Assets | €86 | €148 | €140 | €138 |
| Property Plant & Equip (Net) | €5 | €6 | €9 | €10 |
| Goodwill | €0 | €0 | -€41 | €0 |
| Intangibles | €0 | €0 | €43 | €44 |
| Long-Term Investments | €20 | €10 | €35 | €40 |
| Tax Assets | €0 | €9 | €9 | €5 |
| Other NC Assets | €1 | €11 | €14 | €30 |
| Total NC Assets | €25 | €36 | €68 | €129 |
| Other Assets | €0 | €0 | -€0 | -€0 |
| Total Assets | €111 | €184 | €208 | €267 |
| Liabilities | – | – | – | – |
| Payables | €16 | €9 | €14 | €15 |
| Short-Term Debt | €9 | €9 | €2 | €31 |
| Tax Payable | €0 | €7 | €6 | €7 |
| Deferred Revenue | €1 | €6 | €7 | €13 |
| Other Curr. Liab. | €7 | €9 | €13 | €14 |
| Total Curr. Liab. | €33 | €40 | €41 | €80 |
| LT Debt | €22 | €31 | €40 | €14 |
| Deferred Rev, NC | €3 | €5 | €8 | €25 |
| Deferred Tax Liab, NC | €0 | €9 | €9 | €5 |
| Other NC Liab. | €44 | €39 | €56 | €36 |
| Total NC Liab. | €69 | €93 | €112 | €80 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €0 | €1 | €2 | €3 |
| Total Liabilities | €102 | €132 | €154 | €160 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €4 | €4 | €4 | €4 |
| Retained Earnings | -€386 | -€337 | -€330 | -€272 |
| AOCI | €0 | €0 | €1 | €0 |
| Other Equity | €391 | €384 | €380 | €375 |
| Total Equity | €9 | €52 | €54 | €107 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €111 | €184 | €208 | €267 |
| Net Debt | -€35 | -€31 | -€42 | -€60 |